Typically, an FDA re-inspection comes near the end of the 6-month review period. The FDA’s Daxi review has been ongoing less than 3 months, so it’s quite unlikely that the re-inspection has occurred.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.